Berardi, R., Torniai, M., Pusceddu, S., Spada, F., Ibrahim, T., Brizzi, M. P., . . . Cascinu, S. (2017). Prognostic impact of the cumulative dose and dose intensity of everolimus in patients with pancreatic neuroendocrine tumors. Cancer Med.
Chicago Style CitationBerardi, Rossana, et al. "Prognostic Impact of the Cumulative Dose and Dose Intensity of Everolimus in Patients With Pancreatic Neuroendocrine Tumors." Cancer Med 2017.
Cita MLABerardi, Rossana, et al. "Prognostic Impact of the Cumulative Dose and Dose Intensity of Everolimus in Patients With Pancreatic Neuroendocrine Tumors." Cancer Med 2017.
Atenció: Aquestes cites poden no estar 100% correctes.